U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07081659) titled 'On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation' on July 03.

Brief Summary: Both Silodosin 4 mg and Dapoxetine 60 mg significantly improved IELT and sexual function scores in primary PE patients. However, Silodosin exhibited a more favorable tolerability profile with fewer side effects, making it a safer, clinically effective alternative.

Study Start Date: March 01, 2024

Study Type: INTERVENTIONAL

Condition: Premature (Early) Ejaculation

Intervention: DRUG: sildosin 4mg

ondemand sildosin 4mg

DRUG: dapoxetine 60mg

ondemand dapoxetine 60mg

Recruitment Status: COMPLETED

Sponsor: Benha...